Other Issues:
previous
|
next
|
latest
|
archive
Volume 1(2); 2000
Commentaries
Debate: Does it matter how you lower blood pressure?
Michael H Alderman
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 69–71.
Published online 2000 August 17.
doi: 10.1186/cvm-1-2-069.
PMCID:
PMC59601
|
Abstract
|
Full Text
|
PDF–93K
|
Debate: Are surrogate end-point studies worth the effort?
Jonathan Valabhji and Robert S Elkeles
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 72–75.
Published online 2000 September 12.
doi: 10.1186/cvm-1-2-072.
PMCID:
PMC59602
|
Abstract
|
Full Text
|
PDF–108K
|
Debate: The slippery slope of surrogate outcomes
Ralph B D'Agostino, Jr
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 76–78.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-076.
PMCID:
PMC59603
|
Abstract
|
Full Text
|
PDF–92K
|
Angiotensin receptor blockers in heart failure after the ELITE II trial
Ronnie Willenheimer
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 79–82.
Published online 2000 September 12.
doi: 10.1186/cvm-1-2-079.
PMCID:
PMC59604
|
Abstract
|
Full Text
|
PDF–108K
|
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?
Peter B Berger
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 83–87.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-083.
PMCID:
PMC59605
|
Abstract
|
Full Text
|
PDF–5.0M
|
Clinical applicability of molecular biology: the case of the long QT syndrome
Peter J Schwartz
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 88–91.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-088.
PMCID:
PMC59606
|
Abstract
|
Full Text
|
PDF–116K
|
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
Jacobus Lubsen
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 92–94.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-092.
PMCID:
PMC59607
|
Full Text
|
PDF–90K
|
Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
Sidney Goldstein
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 95–97.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-095.
PMCID:
PMC59608
|
Abstract
|
Full Text
|
PDF–95K
|
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?
Henry H Hsia, Mariell L Jessup, and Francis E Marchlinski
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 98–101.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-098.
PMCID:
PMC59609
|
Abstract
|
Full Text
|
PDF–166K
|
Reviews
Low-molecular-weight heparins in the treatment of venous thromboembolism
Walter Ageno and Menno V Huisman
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 102–105.
Published online 2000 August 29.
doi: 10.1186/cvm-1-2-102.
PMCID:
PMC59610
|
Abstract
|
Full Text
|
PDF–129K
|
Pacing in congestive heart failure
Jayne A Morris-Thurgood and Michael P Frenneaux
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 107–114.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-107.
PMCID:
PMC59611
|
Abstract
|
Full Text
|
PDF–139K
|
Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy
Hubert Seggewiss
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 115–119.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-115.
PMCID:
PMC59612
|
Abstract
|
Full Text
|
PDF–206K
|
Gene therapy for lipid disorders
Masa-aki Kawashiri and Daniel J Rader
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 120–127.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-120.
PMCID:
PMC59613
|
Abstract
|
Full Text
|
PDF–177K
|
Editorial
An essential guide to the literature
William J Penny and John P Bourke
Curr Control Trials Cardiovasc Med.
2000;
1
(2)
: 128.
Published online 2000 October 11.
doi: 10.1186/cvm-1-2-128.
PMCID:
PMC59614
|
Full Text
|
PDF–73K
|
Other Issues:
previous
|
next
|
latest
|
archive
